# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001867096-26-000023
Filing Date
2026-04-23
Accepted
2026-04-23 17:09:12
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | xers2025annualreport.pdf | ARS | 3113354
| Complete submission text file | 0001867096-26-000023.txt |  | 4289621

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40880 | Film No.: 26889631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)